Old Web
English
Sign In
Acemap
>
authorDetail
>
Miren L. Baroja
Miren L. Baroja
University of Pennsylvania
Immunotherapy
Tumor Escape
Nivolumab
LAG3
Tumor antigen
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.
2021
Nature Communications
Adham S. Bear
Tatiana Blanchard
Joseph Cesare
Michael J. Ford
Lee P. Richman
Chong Xu
Miren L. Baroja
Sarah McCuaig
Christina Costeas
Khatuna Gabunia
John Scholler
Avery D. Posey
Mark H. OHara
Smole Anze
Daniel J. Powell
Benjamin A. Garcia
Robert H. Vonderheide
Gerald P. Linette
Beatriz M. Carreno
Show All
Source
Cite
Save
Citations (2)
Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform.
2021
Clinical And Translational Immunology
Gautam N. Shenoy
Christopher J. Greene
Maulasri Bhatta
Miren L. Baroja
Jenni L. Loyall
Sathy V. Balu-Iyer
Raymond J. Kelleher
Beatriz M. Carreno
Gerald P. Linette
Leonard D. Shultz
Richard B. Bankert
Show All
Source
Cite
Save
Citations (2)
1
map